Long-term persistence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein-specific and neutralizing antibodies in recovered COVID-19 patients

Understanding antibody responses after natural severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can guide the coronavirus disease 2019 (COVID-19) vaccine schedule, especially in resource-limited settings. This study aimed to assess the dynamics of SARS-CoV-2 antibodies, includi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chansaenroj, Jira, Yorsaeng, Ritthideach, Puenpa, Jiratchaya, Wanlapakorn, Nasamon, Chirathaworn, Chintana, Sudhinaraset, Natthinee, Sripramote, Manit, Chalongviriyalert, Piti, Jirajariyavej, Supunee, Kiatpanabhikul, Phatharaporn, Saiyarin, Jatuporn, Soudon, Chulikorn, Thienfaidee, Orawan, Ayuthaya, Thitisan Palakawong Na, Brukesawan, Chantapat, Intharasongkroh, Duangnapa, Chaiwanichsiri, Dootchai, Issarasongkhram, Mila, Kitphati, Rungrueng, Mungaomklang, Anek, Thitithanyanont, Arunee, Nagavajara, Pijaya, Poovorawan, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022880/
https://www.ncbi.nlm.nih.gov/pubmed/35446889
http://dx.doi.org/10.1371/journal.pone.0267102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022880/
https://www.ncbi.nlm.nih.gov/pubmed/35446889
http://dx.doi.org/10.1371/journal.pone.0267102

Ejemplares similares